These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2544675)

  • 1. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection.
    Joncas J; Monczak Y; Ghibu F; Alfieri C; Bonin A; Ahronheim G; Rivard G
    J Med Virol; 1989 Jun; 28(2):110-7. PubMed ID: 2544675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
    Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
    Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A; Vetter V; Kreutzer L; Bauer G
    J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution to rapid diagnosis of infectious mononucleosis.
    Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
    Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status towards Epstein-Barr virus in a group of Sicilian children.
    Ammatuna P; Di Stefano R; Arista S; Sammartano F; Bellia L; Formica P; Albeggiani A
    Eur J Epidemiol; 1989 Jun; 5(2):219-23. PubMed ID: 2548891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
    Masucci G; Berkel I; Masucci MG; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
    J Clin Immunol; 1984 Sep; 4(5):369-82. PubMed ID: 6092413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated IgA antibodies to Epstein-Barr virus in children with chronic active Epstein-Barr virus infection.
    Wakiguchi H; Fujieda M; Kubota H; Matsumoto K; Wakiguchi A; Kurashige T; Oda M
    Acta Med Okayama; 1989 Jun; 43(3):193-6. PubMed ID: 2548373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: --serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis--seroepidemiology of EBV in Belgium based on 5178 sera from patients.
    Lamy ME; Favart AM; Cornu C; Mendez M; Segas M; Burtonboy G
    Acta Clin Belg; 1982; 37(5):281-98. PubMed ID: 6297194
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen (EBNA)-positive cells in a lymph-node of a child with severe primary EBV infection.
    Lenoir G; De-The G; Virelizier JL; Griscelli C
    IARC Sci Publ (1971); 1978; (24 Pt 2):733-8. PubMed ID: 221396
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of serologic markers for Epstein-Barr virus.
    Swanston W; Mahony J; McLaughlin B; Chernesky M
    Diagn Microbiol Infect Dis; 1986 Sep; 5(3):235-44. PubMed ID: 3019605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants.
    Dohno S; Maeda A; Ishiura Y; Sato T; Fujieda M; Wakiguchi H
    Pediatr Int; 2010 Aug; 52(4):536-40. PubMed ID: 20113421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.